Minimizing adverse drug events in older patients

American Family Physician

Volumn 76, Issue 12, 2007, Pages 1837-1844

  Pham, Cung B ^a,b   Dickman, Robert L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tufts University School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMIODARONE; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ANOREXIGENIC AGENT; BARBITURIC ACID DERIVATIVE; CHLORDIAZEPOXIDE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; CHLORPROPAMIDE; CYPROHEPTADINE; DEXCHLORPHENIRAMINE MALEATE; DIAZEPAM; DICYCLOVERINE; DIGOXIN; DIPHENHYDRAMINE; DISOPYRAMIDE PHOSPHATE; DOXEPIN; FLUOXETINE; FLURAZEPAM; GUANADREL SULFATE; GUANETHIDINE; HYDROXYZINE EMBONATE; HYOSCYAMINE; LORAZEPAM; OXAZEPAM; PROMETHAZINE; TEMAZEPAM; TRIAZOLAM; TRIPELENNAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAGINEX;

AGING; ALLERGIC REACTION; ANGINA PECTORIS; ARTICLE; CLINICAL PRACTICE; DELIRIUM; DELUSIONAL DISORDER; DEMENTIA; DEPRESSION; DRUG DEPENDENCE; FALLING; FRACTURE; GILLES DE LA TOURETTE SYNDROME; HEALTH SERVICE; HEART FAILURE; HEART INFARCTION; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; HYPOGLYCEMIA; MANIA; ORTHOSTATIC HYPERTENSION; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOSIS; QT INTERVAL; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION;

AGED; DRUG INFORMATION SERVICES; DRUG THERAPY, COMPUTER-ASSISTED; DRUG UTILIZATION; HUMANS; MEDICATION ERRORS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; RISK ASSESSMENT;

EID: 37749003315     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87-94.
2. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-8.
3. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
4. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78:1564-77.
5. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004;52:1349-54.
6. Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 1998;280:1000-5.
7. Beers MH, Ouslander JG, Rollingher I, Reuben D, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.
8. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6.
9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [Published correction appears in Arch Intern Med 2004;164:298]. Arch Intern Med 2003;163:2716-24.
10. Franic DM, Jiang JZ. Potentially inappropriate drug use and health-related quality of life in the elderly. Pharmacotherapy 2006;26:768-78.
11. Fillenbaum GG, Hanlon JT, Landerman LR, Artz MB, O'Connor H, Dowd B, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2004;2:92-101.
12. Perri M III, Menon AM, Deshpande AD, Shinde SB, Jiang R, Cooper JW, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005;39:405-11.
13. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
14. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000;34:338-46.
15. Rigler SK, Perera S, Jachna C, Shireman TI, Eng M. Comparison of the association between disease burden and inappropriate medication use across three cohorts of older adults. Am J Geriatr Pharmacother 2004;2:239-47.
16. Department of Health and Human Services. Center for Medicaid and State Operations/Survey and Certification Group. Accessed April 24, 2007, at: http://www.ascp.com/resources/nhsurvey/upload/CMS_F325_Nutrition_(March_06).pdf.
17. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43.
18. Monane M, Monane S, Semla T. Optimal medication use in elders. Key to successful aging. West J Med 1997;167:233-7.
19. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
20. Bergman-Evans B. Improving medication management for older adult clients. Accessed April 24, 2007, at: http://www.guideline.gov/summary/summary.aspx?ss= 15&doc_id=6222&nbr=3993.
21. Nathan A, Goodyer L, Lovejoy A, Rashid A. 'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract 1999;16:278-82.
22. Fillit HM, Futterman R, Orland BI, Chim T, Susnow L, Picariello GP, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999;5:587-94.
23. American Geriatric Society, British Geriatrics Society, American Academy of Orthopaedic Surgeons Panel on Falls Prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664-72.
24. Hamdy RC, Moore SW, Whalen K, Donnelly JP, Compton R, Testerman F, et al. Reducing polypharmacy in extended care. South Med J 1995;88:534-8.
25. Garcia RM. Five ways you can reduce inappropriate prescribing in the elderly: a systematic review. J Fam Pract 2006;55:305-12.
26. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006;15:23-31.
27. Ayers CR, Sorrell JT, Thorp SR, Wetherell JL. Evidence-based psychological treatments for late-life anxiety. Psychol Aging 2007;22:8-17.
28. Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003;163:356-60.
29. Rimon E, Kagansky N, Cojocaru L, Gindin J, Schattner A, Levy S. Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients? QJM 2004;97:281-7.
30. Sloane PD, Gruber-Baldini AL, Zimmerman S, Roth M, Watson L, Boustani M, et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004;164:2031-7.
31. Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med 2004;19:669-75.
32. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002;162:2217-22.
33. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
34. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dulop R, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology [Published correction appears in JAMA 1999;281:136]. JAMA 1998;279:1877-82.
35. Hutt E, Pepper GA, Vojir C, Fink R, Jones KR. Assessing the appropriateness of pain medication prescribing practices in nursing homes. J Am Geriatr Soc 2006;54:231-9.
36. Nichol M, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999;33:531-40.
37. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review [Published correction appears in JAMA 2003;289:3242]. JAMA 2002;288:2868-79.
38. Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004;33:224-9.
39. Tseng CW, Brook RH, Keeler E, Mangione CM. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. JAMA 2003;290:222-7.
40. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 2004;164:1749-55.
41. Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 2004;82:935-9.
42. Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002;24:302-16.